Ledger.Open graph →
SEC Form D · filed December 10, 2025

NextCure, Inc

Offering
$21.5M
Sold
$21.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BELTSVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

David P. Kabakoff · South San Francisco, CADirectorJohn G. Houston · Beltsville, MDDirectorTimothy G. Mayer · Beltsville, MDExecMichael Richman · GERMANTOWN, MDExec · DirectorElaine V. Jones · Beltsville, MDDirectorUdayan G. Guha · Beltsville, MDExecAnne G. Borgman · Beltsville, MDDirectorSteven P. Cobourn · Rochester, NYExecSourav G. Kundu · Beltsville, MDExecEllen G. Feigal · Beltsville, MDDirectorStephen G. Webster · Beltsville, MDDirectorKevin G. Shaw · Beltsville, MDExecTimothy G. Mayer · Beltsville, MDExecMichael Richman · GERMANTOWN, MDExec · DirectorElaine V. Jones · Beltsville, MDDirectorUdayan G. Guha · Beltsville, MDExecAnne G. Borgman · Beltsville, MDDirectorSteven P. Cobourn · Beltsville, MDExecDavid P. Kabakoff · Beltsville, MDDirectorSourav G. Kundu · Beltsville, MDExecEllen G. Feigal · Beltsville, MDDirectorStephen G. Webster · Beltsville, MDDirectorJohn G. Houston · New Haven, CTDirectorKevin G. Shaw · Beltsville, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗